The civic record
Read. Follow. Verify.Kentucky expands emergency opioid-antagonist access on college campuses and grants civil liability protections to administrators
Last action · January 28, 2026: to Health Services (H)Sponsor: Chad Aull
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
What This Bill Proposed
Kentucky HB 431 requires public postsecondary educational institutions to provide access to s in campus emergency cabinets, broadens immunity from civil and criminal liability for individuals administering the drug in good faith, and allows public schools to keep supplies on premises. The measure also expands the allowable uses of the opioid abatement trust fund to cover campus distribution programs and treatment services.
The measure establishes mandatory campus-wide placement of overdose-reversal drugs at public universities while protecting emergency administrators from legal liability, directly affecting students, campus staff, first responders, and health care providers across the Commonwealth.
- The Kentucky Opioid Abatement Advisory Commission was established to distribute settlement funds related to the opioid crisis. context
Who It Would Have Affected
Groups the bill's text would have affected, as described in the record. Being affected is not a position for or against it.
Public postsecondary educational institutions
Universities and colleges must install emergency opioid antagonist access locations on campus and develop clinical protocols in collaboration with the Department for Public Health.
Licensed health care providers
Providers and certified pharmacists who prescribe or dispense opioid antagonists in good faith are protected from professional disciplinary action.
Students
Students gain campus-wide access to emergency opioid antagonists and rescue equipment.
Key Facts
You don't have to trust us. Each fact below is taken straight from the official document - click any one to see the exact passage, highlighted in the original.
Frequently Asked Questions
What are public universities required to do under this bill?
Are people who administer opioid antagonists protected from lawsuits?
Can K-12 schools keep opioid antagonists on their premises?
What else do you want to know?
News Coverage
Follow the record
Votes, people, money & the original sourceWhere This Stands
This bill did not become law - Died at adjournment · in House committee.
Procedural history
2 actions- Jan 28, 2026HouseCommitteeto Health Services (H)
- Jan 20, 2026HouseIntroducedintroduced in House to Committee on Committees (H)
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →Lobbying Activity
No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.
Full breakdown
Who this bill affects and the strongest case for and against it, written only from the bill’s own text.
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Mandatory Higher Education Access
Shifts campus health requirements by moving from optional opioid antagonist availability to a mandatory installation rule for public postsecondary institutions.
Connected Entities
Sources
apps.legislature.ky.gov
Analysis Score
0–100- Significance20Lowered because this bill did not pass (its text scored 75)
- Controversy15Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz40Current news / social attention level
Publisher tools